Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors

Pharmazie

Volumn 59, Issue 3, 2004, Pages 238-239

  Gao, J Q ^a,b   Alexandre, L S ^a   Tsuda, Y ^a   Katayama, K ^a   Eto, Y ^a   Sekiguchi, F ^a   Mizuguchi, H ^c   Hayakawa, T ^c   Nakayama, T ^d   Yoshie, O ^d   Tsutsumi, Y ^a   Mayumi, T ^a   Nakagawa, Shinsaku ^a  

^a OSAKA UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY   (China)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ARGININE; ASPARTIC ACID; CHEMOKINE; GLYCINE; MCCL17 CHEMOKINE; MCCL21 CHEMOKINE; MCCL22 CHEMOKINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENETICS; CANCER IMMUNOTHERAPY; CANCER INHIBITION; FEMALE; FIBER MUTANT ADENOVIRUS VECTOR; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; TUMOR CELL;

ADENOVIRIDAE; ANIMALS; CHEMOKINES; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MUTATION; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 12144290820     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Campbell JJ, Haraldsen G, Pan J et al. (1999) The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-780.
2. Gao JQ, Tsuda Y, Katayama K et al. (2003) Anti-tumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector. Cancer Res 63: 4420-4425.
3. Godiska R, Chantry D, Raport CJ et al. (1997) Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185: 1595-1604.
4. Hashimoto M, Niwa O, Nitta Y et al. (1989) Unstable expression of E-Cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 80: 459-463.
5. Maric M, Liu Y (1999) Strong cytotoxic T lymphocyte responses to a macrophage inflammatory protein 1 alpha-expressing tumor: linkage between inflammation and specific immunity. Cancer Res 59: 5549-5553.
6. Mizuguchi H, Kay MA, Hayakawa T (2001a) In vitro ligation-based cloning of foreign DNAs into the E3 and E1 deletion regions for generation of recombinant adenovirus vectors. Biotechniques 30: 1112-1114.
7. Mizuguchi H, Koizumi N, Hosono T et al. (2001b) A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 8: 730-735.
8. Mizuguchi H, Kay MA (1998) Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 9: 2577-2583.
9. Nagira M, Imai T, Hieshima K et al. (1997) Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p 13. J Biol Chem 272: 19518-19524.
10. Yoshie O, Imai T, Nomiyama H (2001) Chemokines in immunity. Adv Immunol 78: 57-110.